Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Virios Therapeutics, Inc.

VIRI•NASDAQ
Healthcare
Biotechnology
$0.15
$0.02(12.40%)
U.S. Market opens in 1h 31m

Virios Therapeutics, Inc. (VIRI) Stock Overview

Explore Virios Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap206.5K
P/E Ratio-0.01
EPS (TTM)$-5.75
ROE-8.40%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

VIRI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Virios Therapeutics, Inc. (VIRI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.01 and a market capitalization of 206.5K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-96.40%
1-Month Change
-95.51%
3-Month Change
-96.69%
6-Month Change
-98.50%
Year-to-Date (YTD) Change
-98.94%
1-Year Change
-99.11%
3-Year Change
-99.89%
5-Year Change
-99.96%
All-Time (Max) Change
-99.96%

Contact Information

https://www.virios.com
866 620 8655
44 Milton Avenue, Alpharetta, GA, 30009

Company Facts

40 Employees
IPO DateDec 17, 2020
CountryUS

Frequently Asked Questions